Clinical Trials Browser

Advanced Rectal Cancer

Rectal Neoplasms

Colorectal Neoplasms

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

Rectal Neoplasms

Carcinoma, Hepatocellular

Biliary Tract Neoplasms, Cholangiocarcinoma

Biliary Tract Neoplasms

Adenocarcinoma of the Lower Rectum

Colorectal Neoplasms

Colorectal Neoplasms

Adenocarcinoma Of Esophagus, Adenocarcinoma, Neoplasm Metastasis, Neoplasms

Carcinoma, Hepatocellular

Gastrointestinal Neoplasms, Neoplasm Metastasis, Neoplasms, Recurrence, Colorectal Neoplasms

Neoplasm Metastasis, Stomach Neoplasms

Colorectal Neoplasms

Carcinoma, Hepatocellular

Colonic Neoplasms, Rectal Neoplasms

Esophageal Neoplasms

Rectal Neoplasms

Pathologic Complete Response

Gastroesophageal Adenocarcinoma

Rectal Neoplasms

Colorectal Cancer Metastatic

Colorectal Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

Colorectal Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Carcinoma, Hepatocellular

Locally Advanced Colorectal Carcinoma

Colorectal Neoplasms

Pancreatic Neoplasms

Colonic Neoplasms, Neoplasms

Gastroesophageal Junction Adenocarcinoma

Colorectal Neoplasms

Carcinoma, Hepatocellular

Stomach Neoplasms

Rectal Neoplasms

Colorectal Neoplasms

Locally Advanced Rectal Cancer

Advanced Solid Tumors

Carcinoma, Hepatocellular

Colorectal Neoplasms

Colorectal Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Colorectal Neoplasms

Clinical Trials

Neoadjuvant FOLFOX Therapy With Short Course Radiation and Active Surveillance in Locally Advanced Rectal Cancer

K-BOOST

Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal Cancer

TNT Esophagus

Organ Preservation in Early Rectal Cancer Patients

A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular Carcinoma

SEVILLA

HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer

NOM-ERA

CLEAR-04

CLEAR-02

GRACIE

Efficacy and Safety of Low-dose Bevacizumab Plus Adebrelimab Combined With Transarterial Chemoembolization Followed by Hepatic Arterial Infusion Chemotherapy (TACE-HAIC) as First-line Treatment for Unresectable Hepatocellular Carcinoma: A Single-arm Phase 2 Trial

FUDOSE

CIME

Phase I Trial of 5-Fluorouracil (5FU) -Based Therapy in Combination With Hydroxytyrosol (HT) in Patients With Advanced or Metastatic Colorectal Cancer

Sequential FOLFOX-HAIC-TACE Plus Sintilimab-Bevacizumab Neoadjuvant Therapy Versus Direct Resection in Resectable High-Risk Recurrence Hepatocellular Carcinoma

Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma

PROTECT

MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer

MEND-IT II

Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)

FOBEAR

Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Metastasis

ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer

Intensified Chemotherapy in CRC After Resection of Liver Metastases

CAPRI-3 GOIM

FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma

CIRCULATEIII

JAB-21822 Combined With Chemotherapy and Bevacizumab in Second-line KRAS G12C CRC

NALIRIFOX Plus Targeted Therapy Versus FOLFOX Plus Targeted Therapy as First-line Treatment for Metastatic Colorectal Cancer

Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial.

Immune Checkpoint Inhibitors + Chemotherapy Versus Chemotherapy in the Neoadjuvant Treatment of Locally Advanced Colorectal Cancer

FOXHIPECT4

RADIOPAN

IROCAS

Folfox+Irinotecan+Chemort In Esophageal Cancer

The Phase 1b/IIa, Open-label, Dose Escalation and Dose Expansion to Evaluate Safety, Tolerability, and Preliminary Efficacy of the Combination of HCB101, Cetuximab/Bevacizumab, and FOLFOX/FOLFIRI in Advanced or Metastatic Colorectal Cancer

LIVERPEARL

Systemic Chemotherapy With FOLFOX Plus Atezolizumab & Bevacizumab for Patients With Advanced HCC Who Previously Received Atezolizumab & Bevacizumab

BIG

PANTHER

ONTOP

CinClare-2

A Clinical Trial to Evaluate the Safety, Tolerability and Clinical Efficacy of M3T01 Monotherapy and in Combination With Pembrolizumab and Other Systemic Therapies

ICT-HCC

SAMCO

OPTIPRIME

Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer

Hypo-OPRA